Drug intelligence / Profile preview

Ejiao Buxue Koufuye

Development stage: Unknown
Lead developer: PT Tristar Optima Perkasa
Modality: Classical Binding Small Molecules → Small Molecules
Administration: Oral

Overview

Ejiao Buxue Koufuye is a traditional Chinese herbal formulation in oral liquid form developed and manufactured by Huabao Pharmaceutical (Suzhou Huabao Pharmaceutical Stock Co., Ltd.). The product is primarily composed of Ejiao (donkey-hide gelatin), a traditional medicine ingredient used to replenish qi and nourish the blood. It is indicated for the treatment of symptoms associated with blood deficiency, including anemia, dizziness, and general fatigue. The formulation follows traditional Chinese medicine principles for hematopoiesis and overall health maintenance. It is currently approved and marketed in China as a therapeutic oral liquid and health supplement.

Brand names: Ejiao Buxue Koufuye
Other names: 阿胶补血口服液Ejiao Buxue Oral Liquid

Beyond the preview

Go deeper on Ejiao Buxue Koufuye.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ejiao Buxue Koufuye.

Explore the full profile